However, the striking differences in the effect of FABP4 between cell populations suggests that the role of FABP4 in tumor progression may depend on the underlying risk factor in which cell transformation occurs, as well as the underlying pathology in which the tumor progresses. The gene discussed is FABP4; the disease is neoplasm.